These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 27347115)
41. Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial. Franzone A; Piccolo R; Gargiulo G; Ariotti S; Marino M; Santucci A; Baldo A; Magnani G; Moschovitis A; Windecker S; Valgimigli M JAMA Cardiol; 2016 Oct; 1(7):795-803. PubMed ID: 27572001 [TBL] [Abstract][Full Text] [Related]
42. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Brener SJ; Kirtane AJ; Rinaldi MJ; Stuckey TD; Witzenbichler B; Weisz G; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Brodie BR; Mehran R; McAndrew T; Stone GW Circ Cardiovasc Interv; 2018 Oct; 11(10):e006853. PubMed ID: 30354629 [TBL] [Abstract][Full Text] [Related]
43. Late bare metal stent thrombosis. Oduncu V; Erkol A; Tanboğa IH; Kırma C Turk Kardiyol Dern Ars; 2010 Sep; 38(6):422-5. PubMed ID: 21200123 [TBL] [Abstract][Full Text] [Related]
44. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis. Montalescot G; van 't Hof AW; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Collet JP; Goodman SG; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Licour M; Merkely B; Salhi N; Silvain J; Storey RF; Ten Berg JM; Tsatsaris A; Zeymer U; Vicaut E; Hamm CW; JACC Cardiovasc Interv; 2016 Apr; 9(7):646-56. PubMed ID: 26952907 [TBL] [Abstract][Full Text] [Related]
45. A case of myocardial infarction caused by obstruction of a drug-eluting stent during the perioperative period. Toyama H; Saito K; Anzai H; Kobayashi N; Aihara T; Ejima Y; Yamauchi M JA Clin Rep; 2015; 1(1):22. PubMed ID: 29497654 [TBL] [Abstract][Full Text] [Related]
46. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial. Bhatt DL; Steg PG; Mehta SR; Leiter LA; Simon T; Fox K; Held C; Andersson M; Himmelmann A; Ridderstråle W; Chen J; Song Y; Diaz R; Goto S; James SK; Ray KK; Parkhomenko AN; Kosiborod MN; McGuire DK; Harrington RA; Lancet; 2019 Sep; 394(10204):1169-1180. PubMed ID: 31484629 [TBL] [Abstract][Full Text] [Related]
47. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial. de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681 [TBL] [Abstract][Full Text] [Related]
48. Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor. Barbieri L; Verdoia M; Pergolini P; Nardin M; Rolla R; Marino P; Bellomo G; Suryapranata H; De Luca G; Nutr Metab Cardiovasc Dis; 2016 Apr; 26(4):352-8. PubMed ID: 26857781 [TBL] [Abstract][Full Text] [Related]
49. Long-Term Efficacy of Extended Dual Antiplatelet Therapy After Left Main Coronary Artery Bifurcation Stenting. Cho S; Kim JS; Kang TS; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Song YB; Hahn JY; Choi SH; Gwon HC; Hong MK; Jang Y Am J Cardiol; 2020 Feb; 125(3):320-327. PubMed ID: 31780076 [TBL] [Abstract][Full Text] [Related]
50. Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis. Zhuo X; Zhuo B; Ouyang S; Niu P; Xiao M BMC Pharmacol Toxicol; 2018 Sep; 19(1):54. PubMed ID: 30176938 [TBL] [Abstract][Full Text] [Related]
51. Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy. Baber U; Zafar MU; Dangas G; Escolar G; Angiolillo DJ; Sharma SK; Kini AS; Sartori S; Joyce L; Vogel B; Farhan S; Gurbel P; Gibson CM; Fuster V; Mehran R; Badimon JJ J Am Coll Cardiol; 2020 Feb; 75(6):578-586. PubMed ID: 32057371 [TBL] [Abstract][Full Text] [Related]
52. Twin Circumflex Arteries: A Rare Coronary Artery Anomaly. Coşansu K; Tarık Ağaç M; Kılıç H; Akdemir R; Gündüz H J Tehran Heart Cent; 2018 Jan; 13(1):32-34. PubMed ID: 29997669 [TBL] [Abstract][Full Text] [Related]
53. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial. Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246 [TBL] [Abstract][Full Text] [Related]
54. Rationale and design of the EVOLVE Short DAPT Study to assess 3-month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention. Mauri L; Kirtane AJ; Windecker S; Yeh RW; Dauerman HL; Price MJ; Christen T; Allocco DJ; Meredith IT; Kereiakes DJ Am Heart J; 2018 Nov; 205():110-117. PubMed ID: 30218844 [TBL] [Abstract][Full Text] [Related]
55. Dual left anterior descending coronary artery with origin of short left anterior descending coronary artery from left main shaft: a rare coronary anomaly. Subban V; Murdoch D; Pincus M J Invasive Cardiol; 2014 May; 26(5):E59-60. PubMed ID: 24791728 [TBL] [Abstract][Full Text] [Related]
56. Ticagrelor Leads to Statin-Induced Rhabdomyolysis: A Case Report. Mrotzek SM; Rassaf T; Totzeck M Am J Case Rep; 2017 Nov; 18():1238-1241. PubMed ID: 29167415 [TBL] [Abstract][Full Text] [Related]
57. Intraoperative Gastric Intramural Hematoma: A Rare Complication of Percutaneous Endoscopic Gastrostomy. Lee CC; Ravindranathan S; Choksi V; Pudussery Kattalan J; Shankar U; Kaplan S Am J Case Rep; 2016 Dec; 17():963-966. PubMed ID: 27990013 [TBL] [Abstract][Full Text] [Related]
58. Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome. Paravattil B; Elewa H J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):347-355. PubMed ID: 28587584 [TBL] [Abstract][Full Text] [Related]
59. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel. Raposeiras-Roubín S; Abu-Assi E; D'Ascenzo F; Fernández-Barbeira S; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Quadri G; Rognoni A; Boccuzzi G; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Flores Blanco P; Garay A; Varbella F; Tommassini F; Caneiro Queija B; Cobas Paz R; Cespón Fernández M; Muñoz Pousa I; Gallo D; Morbiducci U; Domínguez-Rodríguez A; Baz-Alonso JA; Valdés M; Cequier Á; Gaita F; Alexopoulos D; Íñiguez-Romo A Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):298-304. PubMed ID: 29954720 [TBL] [Abstract][Full Text] [Related]
60. Clinical outcomes with 6 months dual antiplatelet therapy after implantation of biolimus-A9 drug eluting coronary stents. Cockburn J; Pareek N; Poliacikova P; Saraf S; Williams R; Dhillon G; Robinson D; Gerber R; Hatrick R; Blows L; de Belder A; Hildick-Smith D Int J Cardiol; 2014 Mar; 172(1):185-9. PubMed ID: 24462139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]